Address: c/o Mishcon de Reya Four Station Square Cambridge, GB CB1 2GE
Released:9/2/2025
Regulator:FDA
OsteoSight™ Hip (v1) is a radiology software designed to opportunistically evaluate low bone mineral density from medical images, helping clinicians identify patients at risk for osteoporosis and related fractures.
View detailsSubscribe to join 7,600+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.